Table 2.
Odds ratios and 95% confidence intervals of NAFLD and CSF according to healthy lifestyle scores.
| Liver Disease | Healthy Lifestyle Score (HLS) † | Per 1 Score | Ptrend ¶ | ||
|---|---|---|---|---|---|
| Low HLS | Medium HLS | High HLS | |||
| NAFLD | |||||
| No. of cases/participants | 270/547 | 989/2434 | 178/912 | ||
| Model 1 ‡ | 1 | 0.70 (0.58~0.85) | 0.25 (0.20~0.31) | 0.66 (0.62~0.70) | <0.001 |
| Model 2 § | 1 | 0.71 (0.58~0.89) | 0.25 (0.19~0.33) | 0.66 (0.61~0.71) | <0.001 |
| CSF | |||||
| No. of cases/participants | 64/547 | 210/2434 | 27/912 | ||
| Model 1 ‡ | 1 | 0.71 (0.53~0.96) | 0.23 (0.15~0.37) | 0.69 (0.62~0.77) | <0.001 |
| Model 2 § | 1 | 0.81 (0.58~1.12) | 0.30 (0.18~0.50) | 0.76 (0.67~0.86) | <0.001 |
Abbreviations: CSF, clinically significant fibrosis; NAFLD, Non-alcoholic fatty liver diseases. † Low HLS: 0–1 score; Medium HLS: 2–3 score; High HLS: 4–5 score. ‡ Model 1 did not adjust for the covariates. § Model 2 was adjusted for age (18–39, 40–59, ≥60), sex (male, female), race/ethnicity (non-Hispanic white, non-Hispanic black, and other races), education (less than high school, high school diploma, and more than high school), the ratio of family income to poverty (<1.30, 1.30–3.49, and ≥3.50), hypertension (yes, no), and diabetes (yes, no). ¶ The trend test was performed by using HLS as a continuous variable in the models.